Echocardiography. 2026 Jul;43(7):e70554. doi: 10.1111/echo.70554.
ABSTRACT
BACKGROUND: Global longitudinal strain (GLS) can detect subclinical dysfunction missed by left ventricular ejection fraction (LVEF). We aim to quantify the magnitude of myocardial dysfunction using GLS across the phases of Kawasaki disease (KD).
METHOD: We systematically searched for studies comparing GLS measurements between children with KD and age-matched controls. Effect sizes were pooled using a random-effects model and reported as standardized mean differences (SMD) for the acute and chronic disease phases. SMDs were re-expressed as mean differences (MDs) using pooled weighted standard deviations (SDs) of 2.75% and 1.89% for the control groups in the acute and chronic phases, respectively.
RESULTS: We included 18 observational studies comprising 907 KD patients and 764 controls. KD patients demonstrated significant GLS depression compared with controls in both the acute (SMD: 1.34, 95% CI: 0.73, 1.95, p < 0.0001, I2 = 93%; MD: 3.6%) and chronic (SMD: 0.72, 95% CI: 0.20, 1.25, p = 0.007, I2 = 92%; MD: 1.9%) phases. LVEF was reduced in the acute phase (MD: -1.09%, 95% CI: -1.57, -0.61, I2 = 0%), and normalized in the chronic phase (MD: -0.27%, 95% CI: -1.18, 0.64, I2 = 36%). Multivariable meta-regression in the acute phase identified CRP (β = 0.02, p = 0.024) plus CAA patient proportion (β = -1.13, p = 0.069) explaining 49.28% of heterogeneity, whereas vendor platform (GE vs. Philips) (β = -1.02, p = 0.007) plus age at follow-up (β = 0.02, p = 0.019) explained 56.34% of heterogeneity in the chronic phase.
CONCLUSIONS: Despite LVEF normalization in the chronic phase of KD, myocardial dysfunction persists. This could be essential for long-term monitoring algorithms.
PMID:42475308 | DOI:10.1111/echo.70554